REZOLUTE, INC. Variable Lease, Cost
REZOLUTE, INC. (RZLT) reported Variable Lease, Cost of $100.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-09-24
- REZOLUTE, INC. variable lease, cost for fiscal 2026 was $100.00K, a 0.00% change from fiscal 2025.
- REZOLUTE, INC. variable lease, cost for fiscal 2025 was $100.00K, a 0.00% change from fiscal 2024.
- REZOLUTE, INC. variable lease, cost for fiscal 2024 was $100.00K.
| Period end | Variable Lease, Cost 12 month |
|---|---|
| 2026-06-30 | $100.00K 10-K · filed 2026-09-24 |
| 2025-06-30 | $100.00K 10-K · filed 2026-09-24 |
| 2024-06-30 | $100.00K 10-K · filed 2025-09-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |